美国银行全球研究下调Inspire Medical Systems评级至"跑输大盘",目标价大幅削减至39美元

美股速递
May 22

美国银行全球研究发布最新评级报告,将睡眠呼吸障碍治疗设备公司Inspire Medical Systems的投资评级从"中性"大幅下调至"跑输大盘"。与此同时,分析师团队将其目标股价从原先的53美元显著调降至39美元,降幅超过26%,显示出对该股未来表现的谨慎预期。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10